PITTSBURGH – A Monroeville resident has been indicted by a federal grand jury in Pittsburgh on charges of distribution of Oxycodone, a Schedule II controlled substance, outside the usual course of professional practice, and omitting material information from required reports, records and other documents, United States Attorney David J. Hickton announced today.
The seven-count indictment, returned on June 7 and unsealed on Monday, named Daniel Garner, 44, a dentist who practices in Pittsburgh, Pennsylvania, as the sole defendant.
According to the indictment, from Feb. 13, 2014 through June 11, 2015, Garner distributed Oxycodone on six occasions, a Schedule II controlled substance, outside the usual course of professional practice. The indictment further alleges that on Jan. 14, 2016, Garner omitted material information from an application for a Drug Enforcement Agency registration number.
The law provides for a maximum total sentence on all counts of incarceration of up to 124 years, a fine of $6,250,000, a term of supervised release of three years, or both. Under the Federal Sentencing Guidelines, the actual sentence imposed would be based upon the seriousness of the offenses and the prior criminal history, if any, of the defendant.
Assistant United States Attorney Cindy K. Chung is prosecuting this case on behalf of the government.
The Drug Enforcement Administration and the Federal Bureau of Investigation conducted the investigation that led to the prosecution of Daniel Garner.